✅ This trial is currently recruiting volunteers
If you think you might be eligible, speak to your GP or specialist about this trial before applying.
Status
Recruiting
Phase
PHASE1
Participants
ALL
Age Range
18 Years โ 65 Years
About This Trial
This study evaluates the safety and tolerability of CHF10136 administered by inhalation in healthy adults and adults with asthma. The study includes single-dose, multiple-dose, and repeated-dose treatment periods and will also characterize the pharmacokinetic profile of CHF10136.
Who Can Join?
INCLUSION CRITERIA For PART 1 – SAD * Healthy male or female participant โฅ18 and โค55 years of age * Body mass index (BMI) โฅ18 and โค30 kg/m2 at screening and weight at least 50 kg; * Good physical and mental status, determined via assessment of medical history at screening and physical examination at screening and prior to randomisation; * Spirometry measurements within normal limits at screening and prior to randomisation based on the American Thoracic Society (ATS)/European Respiratory Society (ERS) interpretative strategies for spirometry. The forced expiratory volume in the first second (FEV1) must be >80% of predicted normal value and the FEV1/Forced Vital Capacity (FVC) ratio must be >0.7. * Male and Female participants willing and able to comply with study procedures For PART 2 – MAD * Male or female participants โฅ18 and โค55 years of age at screening * BMI โฅ18 and โค32 kg/m2 at screening…
⚠ Always speak to your doctor before applying to any clinical trial.
More Lung & Breathing Trials
Recruiting PHASE2
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate…
Recruiting PHASE1A Study of RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
Recruiting NABronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung – Study 3